Frank T. Watkins - 16 Nov 2021 Form 4 Insider Report for Shockwave Medical, Inc.

Role
Director
Signature
/s/ Wade Estey, as attorney-in-fact for Frank T. Watkins
Issuer symbol
N/A
Transactions as of
16 Nov 2021
Net transactions value
-$835,955
Form type
4
Filing time
18 Nov 2021, 15:58:58 UTC
Previous filing
21 Oct 2021
Next filing
30 Dec 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SWAV Common Stock Sale $10,405 -51 -0.09% $204.02 59,751 16 Nov 2021 Direct F1, F2
transaction SWAV Common Stock Sale $33,975 -165 -0.28% $205.91 59,586 16 Nov 2021 Direct F3
transaction SWAV Common Stock Sale $63,716 -308 -0.52% $206.87 59,278 16 Nov 2021 Direct F4
transaction SWAV Common Stock Sale $50,114 -241 -0.41% $207.94 59,037 16 Nov 2021 Direct F5
transaction SWAV Common Stock Sale $146,697 -702 -1.2% $208.97 58,335 16 Nov 2021 Direct F6
transaction SWAV Common Stock Sale $102,021 -486 -0.83% $209.92 57,849 16 Nov 2021 Direct F7
transaction SWAV Common Stock Sale $9,898 -47 -0.08% $210.60 57,802 16 Nov 2021 Direct F8
transaction SWAV Common Stock Sale $68,575 -332 -0.57% $206.55 57,470 17 Nov 2021 Direct F9
transaction SWAV Common Stock Sale $82,350 -397 -0.69% $207.43 57,073 17 Nov 2021 Direct F10
transaction SWAV Common Stock Sale $35,433 -170 -0.3% $208.43 56,903 17 Nov 2021 Direct F11
transaction SWAV Common Stock Sale $40,393 -193 -0.34% $209.29 56,710 17 Nov 2021 Direct F12
transaction SWAV Common Stock Sale $28,625 -136 -0.24% $210.48 56,574 17 Nov 2021 Direct F13
transaction SWAV Common Stock Sale $129,314 -610 -1.1% $211.99 55,964 17 Nov 2021 Direct F14
transaction SWAV Common Stock Sale $34,440 -162 -0.29% $212.59 55,802 17 Nov 2021 Direct F15
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 11/16/2020.
F2 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $204.01 to $204.02. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F3 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $205.32 to $206.29. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F4 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $206.33 to $207.31. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F5 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $207.47 to $208.44. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F6 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $208.47 to $209.44. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F7 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $209.51 to $210.39. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F8 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $210.52 to $210.67. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F9 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $205.90 to $206.79. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F10 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $206.98 to $207.92. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F11 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $207.99 to $208.98. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F12 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $208.99 to $209.89. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F13 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $210.03 to $211.02. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F14 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $211.40 to $212.27. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F15 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $212.43 to $212.80. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.